2 buy-rated ASX healthcare shares

ResMed Inc. (ASX:RMD) and this ASX healthcare shares have been given buy ratings. Here's why they could be shares to own…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The healthcare sector has been a great place to invest over the last few years. Thanks to increasing demand due to a number of industry tailwinds, this side of the market has flourished.

The good news is that demand continues to increase and looks unlikely to stop doing so for some time to come. This could make the sector a great place to invest with a long term view.

But which ASX healthcare shares should you buy? Two to consider are listed below:

Rising healthcare ASX share price represented by doctor giving thumbs up

Image source: Getty Images

Ramsay Health Care Limited (ASX: RHC)

Few companies will benefit from increasing demand for healthcare services more than Ramsay Health Care. It is a leading private healthcare company with operations across the world.

While the pandemic led to a significant drop in elective surgeries, trading conditions have been improving greatly. As a result, Ramsay looks well-placed to benefit from a backlog in surgeries in the near term and increased demand for healthcare services over the long term. 

In addition to this, the company has a long history of accelerating its growth through acquisitions. And given its strong balance sheet, it wouldn't be overly surprising to see the company make another purchase in the near term.

One broker that is a fan of Ramsay is Macquarie. Its analysts have an outperform rating and $75.00 price target on its shares.

ResMed Inc. (ASX: RMD)

Another quality healthcare share to look at is ResMed. It is one of the world's leading sleep treatment-focused medical device companies.

Thanks to its industry-leading products, growing software business, the increasing awareness of sleep disorders, and its investment in R&D, ResMed has been growing at a consistently strong rate for a number of years.

Positively, the company still has a long runway for growth. This is thanks to its huge addressable market and the shift to home healthcare. The latter is being supported by its comprehensive out-of-hospital software platforms.

Morgans is bullish on ResMed. It currently has an add rating and $30.09 price target on its shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A cool white-bearded man holds his hand up signalling you should halt.
Healthcare Shares

ASX 300 cannabis stock Incannex suspended ahead of 'material update'

The Incannex share price is frozen at 14 cents for now.

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

Guess which ASX All Ords stock is rocketing 27% on a new FDA approval

Rett Syndrome has finally got an approved treatment.

Read more »

Five healthcare workers standing together and smiling.
Healthcare Shares

Buy these excellent ASX 200 healthcare shares: Goldman Sachs

Goldman has spoken very positively about these healthcare shares this week.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
Healthcare Shares

Should I buy CSL shares while they're under $300?

Can investors make a healthy return with this biotech?

Read more »

A man wearing a white coat holds his hands up and mouth open with joy.
Healthcare Shares

Mesoblast share price rockets 23% on FDA news

Mesoblast has received some good news for the US FDA this morning.

Read more »

A young woman wearing a blue blouse with white polkadots holds her phone up with an intrigued and happy look on her face as she reads some news.
Healthcare Shares

Owners of this ASX 200 share are soon going to receive a bigger dividend

Investors in this healthcare company are about to get a healthy cash boost.

Read more »

an older couple look happy as they sit at a laptop computer in their home.
Healthcare Shares

Hoping to collect the latest CSL dividend? Here's how

The next CSL dividend is fast approaching.

Read more »